Sanofi, FR0000120578

Sanofi Stock - Thursday technicals after recent slide

18.06.2026 - 20:47:48 | ad-hoc-news.de

Sanofi stock trades lower this week, with German quotes showing a drop of more than 2% on Thursday. With no fresh corporate news, today’s focus shifts to the chart picture and how the pharma heavyweight compares with its sector peers.

Sanofi, FR0000120578
Sanofi, FR0000120578

Edited by ad hoc news Chart & Technicals Desk. Verified prior to publication on 06/18/2026, 18:40 CET. Details in the imprint.

Sanofi (FR0000120578) remains under technical scrutiny on Thursday after a noticeable midweek drop in the share price. With no fresh ad-hoc releases or major analyst rating changes confirmed today, the focus turns to the current chart setup and recent volatility.

Go deeper

All news and data on Sanofi stock

Stay on top of price moves, company news and regulatory filings relating to Sanofi stock with the dedicated topic page and the group’s own investor-relations portal.

What Thursday’s charts show

On German trading platforms, Sanofi shares recently changed hands at around EUR 73.30, with Xetra showing EUR 73.24 and a daily loss of about 2.2% in delayed data on Thursday morning. The move puts the stock closer to the lower end of its recent trading range.

Onvista quote pages highlight intraday declines of more than 2% on various German venues, underscoring a weak session for the pharma group’s shares. Trading volumes appear solid, suggesting institutional participation rather than purely retail-driven flows.

Thursday focus on technical picture

With no new corporate guidance or transaction news, Thursday’s focus falls squarely on chart levels, recent volatility and how Sanofi trades versus the broader pharmaceutical sector. The stock has been fluctuating within a wide corridor over recent months.

Sector trackers show European pharma names trading mixed, with Sanofi’s weakness on the day slightly underperforming some large-cap peers. That underperformance keeps the stock under observation for potential shifts in relative strength within the CAC 40 and Euro STOXX health-care space.

How the company makes money

Sanofi generates most of its revenue from prescription medicines in areas such as immunology, rare diseases, vaccines and general medicines, complemented by consumer health brands. The group develops, manufactures and markets these products globally, with Europe and the United States as key profit centers.

Where the stock trades today

The shares of Sanofi (FR0000120578) most recently trade on Xetra at EUR 73.24 as of 06/18/2026, 10:41 CET.

Key facts on Sanofi stock

  • Company: Sanofi S.A.
  • ISIN: FR0000120578
  • WKN: 920657
  • Ticker: SAN
  • Venue: Xetra
  • Price (as of 06/18/2026, 10:41 CET): 73.24 EUR
  • Market cap: 92,000,000,000 EUR (as of 06/18/2026)
  • Sector / Industry: Health Care / Pharmaceuticals
  • Index membership: CAC 40, Euro STOXX 50, STOXX Europe 600
  • Next earnings date: 07/25/2026

Sanofi stock on social media

This article was AI-assisted and editorially reviewed. Price and company data without warranty; prices and dates may change at short notice. No investment advice, no buy or sell recommendation. Trading securities involves risk up to total loss of capital.

en | FR0000120578 | SANOFI | boerse | 69575876 | bgmi